financetom
Business
financetom
/
Business
/
CarMax Accelerates Used Car Sales Growth, Despite Earnings Miss
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CarMax Accelerates Used Car Sales Growth, Despite Earnings Miss
Apr 10, 2025 6:22 AM

CarMax, Inc. ( KMX ) shares are trading higher after the company reported fourth-quarter earnings results.

Quarterly sales of $6 billion beat the street view of $5.96 billion.

Retail used unit sales rose by 6.2% Y/Y

Comparable store used unit sales increased by 5.1% Y/Y

Wholesale units increased 3.1% Y/Y.

The company reported earnings per share of 58 cents, missing the analyst consensus estimate of 68 cents.

CarMax Auto Finance income was $159.3 million, an increase of 8.2 % year over year (Y/Y)

The provision for loan losses stood at $68.3 million vs. $71.6 million a year ago quarter.

Gross profit per retail used unit was $2,322 (up $71 per unit), and gross profit per wholesale unit was $1,045 (down $75 per unit).

The Extended Protection Plan margin increased by $10 per retail unit to $580.

In the fourth quarter, the company repurchased 1.2 million shares of common stock for $98.5 million.

Buyback: As of Feb. 28, the company had $1.94 billion remaining available for repurchase under the outstanding authorization.

The company exited the quarter with cash and equivalents worth $247 million. Restricted cash from collections on auto loans receivable totaled $559.1 million.

Inventories at quarter-end stood at $3.935 billion.

Outlook: For fiscal year 2026, the company plans to open new store growth of six locations, as well as four stand-alone reconditioning/auction centers.

The company projects capital expenditures of around $575 million in FY26.

The year-over-year increase is mainly due to the timing of land purchases, which were deferred from fiscal year 2025 to fiscal year 2026.

Investors can gain exposure to the stock via Valued Advisers Trust Kovitz Core Equity ETF and Invesco S&P 500 Equal Weight Consumer Discretionary ETF .

Price Action: KMX shares are trading higher by 6.44% to $86.66 premarket at last check Thursday.

Read Next:

US Stocks Likely To Open Lower Ahead Of March Inflation Release: Expert Highlights ‘Fairly Weak Returns’ After 5%+ Gains In S&P 500

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-Sanctions-hit Belarus looks at Gambia to boost depleted fleet
Exclusive-Sanctions-hit Belarus looks at Gambia to boost depleted fleet
Mar 26, 2025
LONDON (Reuters) - Sanctions-hit Belarusian flag carrier Belavia is on the cusp of adding three Airbus planes to its depleted fleet after repurposing aircraft that had previously belonged to Gambian airline Magic Air , three people familiar with the matter told Reuters. Western sanctions imposed on Belarus and its larger neighbour Russia after Minsk forced a Ryanair plane to land...
Bosch to start electrolyser parts production, eyes billions in hydrogen revenue
Bosch to start electrolyser parts production, eyes billions in hydrogen revenue
Mar 26, 2025
BERLIN, March 26 (Reuters) - Bosch will begin producing electrolyser components for hydrogen production, expecting its hydrogen business to generate billions of euros in revenue by 2030, the company said on Wednesday. Germany wants to expand reliance on hydrogen as a future energy source to cut greenhouse gas emissions for highly polluting industrial sectors that cannot be electrified such as...
JinkoSolar Holding Swings to Q4 Loss, Revenue Falls
JinkoSolar Holding Swings to Q4 Loss, Revenue Falls
Mar 26, 2025
05:27 AM EDT, 03/26/2025 (MT Newswires) -- JinkoSolar Holding ( JKS ) reported a Q4 loss Wednesday of 9.22 renminbi ($1.26) per diluted American depositary share, swinging from earnings of 0.54 renminbi a year earlier. Three analysts polled by FactSet expected a loss of 3.06 renminbi. Revenue for the quarter ended Dec. 31 was 20.65 billion renminbi, down from 32.83...
Theratechnologies Shares Soar Premarket on FDA Approval of New Formulation of Excess Abdominal Fat Treatment
Theratechnologies Shares Soar Premarket on FDA Approval of New Formulation of Excess Abdominal Fat Treatment
Mar 26, 2025
05:17 AM EDT, 03/26/2025 (MT Newswires) -- Theratechnologies ( THTX ) shares were up 50% in recent premarket activity Wednesday after the company said overnight that the US Food and Drug Administration approved its supplemental biologics license application for the new formulation of tesamorelin to be used as an injection. The company said the tesamorelin injection is approved in the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved